About Guildford Pharmaceuticals
Guildford Pharmaceuticals was a Healthcare company based in Woodcliff Lake (United States) founded in 1996, and was acquired by MGI Pharma in July 2005. A US-based specialty pharmaceutical company developing small molecule therapeutics for cancer and neurology. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Development and Cancer and Neurology Therapeutics.
Company details
Guildford Pharmaceuticals a us-based specialty pharmaceutical company developing small molecule therapeutics for cancer and neurology, focusing on providing healthcare solutions, producing pharmaceutical products, drug development, and cancer and neurology therapeutics. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Woodcliff Lake, United States
- Stage Acquired
- SectorsHealthcare
- Website ww25.guilfordpharm.com/?subid1=20250326-1220-4594-b261-f04d31757e0b
- Acquired by MGI Pharma (Jul 2005)
- Investors
- Acquired byMGI Pharma
(Jul 2005)
Investors in Guildford Pharmaceuticals
Guildford Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include MGI Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Oncology and acute care pharmaceuticals are developed and commercialized. | 1979 | mgipharma.com | Woodcliff Lake, United States |
Investor details for Guildford Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Guildford Pharmaceuticals
2 dated milestones of Guildford Pharmaceuticals across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Guildford Pharmaceuticals is founded.
- Exit Acquired by MGI Pharma.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Guildford Pharmaceuticals (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Guildford Pharmaceuticals
Guildford Pharmaceuticals was founded in 1996.
Guildford Pharmaceuticals is headquartered in Woodcliff Lake, United States. It is registered at Woodcliff Lake, New Jersey, United States.
Guildford Pharmaceuticals a us-based specialty pharmaceutical company developing small molecule therapeutics for cancer and neurology, focusing on providing healthcare solutions, producing pharmaceutical products, drug development, and cancer and neurology therapeutics. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Guildford Pharmaceuticals has 1 investor. Key investors include MGI Pharma.
Yes. Guildford Pharmaceuticals was acquired by MGI Pharma in July 2005.